Cargando…
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus
Capripox virus (CaPV)-induced diseases (lumpy skin disease, sheeppox, goatpox) are described as the most serious pox diseases of livestock animals, and therefore are listed as notifiable diseases under guidelines of the World Organisation for Animal Health (OIE). Until now, only live-attenuated vacc...
Autores principales: | Wolff, Janika, Moritz, Tom, Schlottau, Kore, Hoffmann, Donata, Beer, Martin, Hoffmann, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823700/ https://www.ncbi.nlm.nih.gov/pubmed/33374808 http://dx.doi.org/10.3390/vaccines9010004 |
Ejemplares similares
-
High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate
por: Wolff, Janika, et al.
Publicado: (2022) -
Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep
por: Wolff, Janika, et al.
Publicado: (2023) -
Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia
por: Wolff, Janika, et al.
Publicado: (2020) -
Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle
por: Wolff, Janika, et al.
Publicado: (2021) -
Review: Vaccines and Vaccination against Lumpy Skin Disease
por: Tuppurainen, Eeva, et al.
Publicado: (2021)